A series of cases of transthyretin amyloid cardiomyopathy with negative bone scintigraphy but a confirmed positive endomyocardial biopsy
Orphanet Journal of Rare Diseases · 15.10.2024 · 19 (1)
DOI: 10.1186/s13023-024-03401-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Orphanet Journal of Rare Diseases, online erschienen am 15.10.2024. Verfasst von Antoine Fraix und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Institut Lorrain du Cœur et des Vaisseaux, Nancy University Medical Center, 54000, Nancy, France. antoine.fraix@gmail.com. Hauptthemen laut MEDLINE: Cardiomyopathies, Radionuclide Imaging, Amyloid Neuropathies, Familial. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Bone scintigraphy (BS) is established as an accurate, non-invasive method for the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM). In a real-life setting, however, some patients with no cardiac uptake on BS turn out to have cardiac-biopsy-confirmed ATTR-CM. We retrospectively included all patients diagnosed at the French Referral Center for ATTR-CM and who had data for BS and a cardiac biopsy.
Results
Of 271 patients with positive cardiac biopsy, 14 (5%) had no cardiac uptake on 99m Tc-hydroxymethylene diphosphonate BS. Cardiac uptake was found in four of the seven patients who had a second BS assessment with 99m Tc-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD). A retrospective review of the BS data found low cardiac uptake in four patients (two with HMDP and two with both radiotracers). Ultimately, six of the 14 patients with a biopsy-confirmed diagnosis of ATTR-CM did not show any cardiac radiotracer uptake.
Conclusions
An endomyocardial biopsy may be necessary for confirming the diagnosis of ATTR-CM in patients with clinical and imaging signs of cardiac amyloidosis but no cardiac radiotracer uptake in BS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiology Department, Institut Lorrain du Cœur et des Vaisseaux, Nancy University Medical Center, 54000, Nancy, France. antoine.fraix@gmail.com.
- AP-HP (Assistance Publique-Hôpitaux de Paris), Nuclear Medicine Department, Henri Mondor University Medical Center, 51 Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil, France.
- AP-HP (Assistance Publique-Hôpitaux de Paris), French National Reference Center for Cardiac Amyloidosis, Cardiogen Network, Henri Mondor University Medical Center, 51 Avenue du Maréchal de Lattre de Tassigny, 94010, Cré…
- AP-HP (Assistance Publique-Hôpitaux de Paris), GRC Amyloid Research Institute, Henri Mondor University Medical Center, 51 Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil, France.
- IMRB, Inserm, University Paris Est Créteil, 94000, Creteil, France.
- AP-HP (Assistance Publique-Hôpitaux de Paris), Cardiology Department, Henri Mondor University Medical Center, 51 Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil, France.
ORCID-Profile: Antoine Fraix
Zitieren
APA
Fraix, A., Itti, E., Zaroui, A., Kharoubi, M., Poullot, E., Lerman, L., Guendouz, S., Huttin, O., Damy, T., & Galat, A. (2024). A series of cases of transthyretin amyloid cardiomyopathy with negative bone scintigraphy but a confirmed positive endomyocardial biopsy. Orphanet Journal of Rare Diseases, 19(1). https://doi.org/10.1186/s13023-024-03401-9
Vancouver
Fraix A, Itti E, Zaroui A, Kharoubi M, Poullot E, Lerman L, et al. A series of cases of transthyretin amyloid cardiomyopathy with negative bone scintigraphy but a confirmed positive endomyocardial biopsy. Orphanet Journal of Rare Diseases. 2024;19(1). doi:10.1186/s13023-024-03401-9
BibTeX
@article{Fraix2024,
author = {Fraix, Antoine and Itti, Emmanuel and Zaroui, Amira and Kharoubi, Mounira and Poullot, Elsa and Lerman, Lionel and Guendouz, Soulef and Huttin, Olivier and Damy, Thibaud and Galat, Arnault},
title = {A series of cases of transthyretin amyloid cardiomyopathy with negative bone scintigraphy but a confirmed positive endomyocardial biopsy},
journal = {Orphanet Journal of Rare Diseases},
year = {2024},
volume = {19},
number = {1},
doi = {10.1186/s13023-024-03401-9}
}
EUVIMED